On Wednesday, 19 May 2010, the launch of the 2.3(c) Committee will take place at Room XXV of the Palais de Nations from 13:00 to 14:30. Element 2.3(c) of the WHO Global Strategy on Public Health, Innovation and Intellectual Property states:
encourage further exploratory discussions on the utility of possible instruments or mechanisms for essential health and biomedical R&D, including inter alia, an essential health and biomedical R&D treaty
At the 62nd World Health Assembly, member countries agreed that the stakeholders that would implement element 2.3(c) included: Interested governments; other relevant stakeholders (including nongovernmental organizations)
Public interest NGOs and WHO member states will provide their perspectives on how implement the Global Strategy’s language on an essential health and biomedical R&D treaty.